Evidence map›Paper›PMID 25995384›Full record

ArticleMolecular cancer research : MCR2015

ZBTB7A Suppresses Melanoma Metastasis by Transcriptionally Repressing MCAM.

Xue-Song Liu, Matthew D Genet, Jenna E Haines, Elie K Mehanna, Shaowei Wu, Hung-I Harry Chen, Yidong Chen, Abrar A Qureshi, Jiali Han, Xiang Chen and 3 more

Abstract read
In one paragraph

Article in Molecular cancer research : MCR, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 25 papers.

0numbers the graph read from it
0cells of the map it votes in
25citing papers in PubMed
2.4field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

25 citing papers in PubMed, 48 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. TheFrontiers in oncology · 2020
    Article
  15. Article
  16. Article
  17. Review
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 7 institutions in 2 countries.

Xue-Song LiuDepartment of Genetics and Complex Diseases, Harvard School of Public Health, Boston, Massachusetts.
Matthew D GenetDepartment of Genetics and Complex Diseases, Harvard School of Public Health, Boston, Massachusetts.
Jenna E HainesDepartment of Genetics and Complex Diseases, Harvard School of Public Health, Boston, Massachusetts.
Elie K MehannaDepartment of Genetics and Complex Diseases, Harvard School of Public Health, Boston, Massachusetts.
Shaowei WuBrigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts.
Hung-I Harry ChenDepartment of Epidemiology and Biostatistics, University of Texas Health Science Center at San Antonio, San Antonio, Texas.
Yidong ChenDepartment of Epidemiology and Biostatistics, University of Texas Health Science Center at San Antonio, San Antonio, Texas.
Abrar A QureshiWarren Alpert Medical School, Brown University, Providence, Rhode Island.
Jiali HanBrigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts.
Xiang ChenXiangya Hospital, Central South University, Changsha, Hunan, P.R. China.
David E FisherDepartment of Dermatology, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts.
Pier Paolo PandolfiCancer Genetics Program, Beth Israel Deaconess Cancer Center, Departments of Medicine and Pathology, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts.
Zhi-Min YuanDepartment of Genetics and Complex Diseases, Harvard School of Public Health, Boston, Massachusetts. zyuan@hsph.harvard.edu.
Harvard University · USBrigham and Women's Hospital · USThe University of Texas Health Science Center at San Antonio · USBeth Israel Deaconess Medical Center · USBrown University · USCentral South University · CNMassachusetts General Hospital · US

Funding

Transcriptional mechanisms and melanomaP01CA163222 · NCI · MASSACHUSETTS GENERAL HOSPITAL · PI Kai W Wucherpfennig · 2013 to 2026
$25.3M
The MITF transcriptional network: melanoma risk and carcinogenesisR01AR043369 · NIAMS · MASSACHUSETTS GENERAL HOSPITAL · PI DAVID E FISHER · 1996 to 2026
$9.4M
Targeting Tumor Suppressive Pathways for Cancer TherapyR35CA197529 · NCI · BETH ISRAEL DEACONESS MEDICAL CENTER · PI PANDOLFI, PIER PAOLO · 2015 to 2019
$4.6M
MOLECULAR BASIS OF P53 INDUCTION TO DNA DAMAGER01CA085679 · NCI · UNIVERSITY OF TEXAS HLTH SCIENCE CENTER · PI YUAN, ZHI-MIN · 2001 to 2015
$3.4M
Modulation of p53 function by tyrosine kinase networksR01CA167814 · NCI · HARVARD SCHOOL OF PUBLIC HEALTH · PI YUAN, ZHI-MIN · 2012 to 2016
$1.6M
The role of beclin 1/class III PI-3 kinase and p53 in breast tumorigenesisR01CA125144 · NCI · UNIVERSITY OF TEXAS HLTH SCIENCE CENTER · PI YUAN, ZHI-MIN · 2008 to 2012
$1.5M
NCI NIH HHS P01 CA163222NCI NIH HHS R01 CA085679NCI NIH HHS R01CA085679NCI NIH HHS R01 CA125144NCI NIH HHS R01CA125144NCI NIH HHS R01 CA167814NCI NIH HHS R01CA167814NCI NIH HHS R35 CA197529NIAMS NIH HHS R01 AR043369
6 · The paper itself

Abstract

unlabelledThe excessive metastatic propensity of melanoma makes it the most deadly form of skin cancer, yet the underlying mechanism of metastasis remains elusive. Here, mining of cancer genome datasets discovered a frequent loss of chromosome 19p13.3 and associated downregulation of the zinc finger transcription factor ZBTB7A in metastatic melanoma. Functional assessment of ZBTB7A-regulated genes identified MCAM, which encodes an adhesion protein key to melanoma metastasis. Using an integrated approach, it is demonstrated that ZBTB7A directly binds to the promoter and transcriptionally represses the expression of MCAM, establishing ZBTB7A as a bona fide transcriptional repressor of MCAM. Consistently, downregulation of ZBTB7A results in marked upregulation of MCAM and enhanced melanoma cell invasion and metastasis. An inverse correlation of ZBTB7A and MCAM expression in association with melanoma metastasis is further validated with data from analysis of human melanoma specimens. IMPLICATIONS: Together, these results uncover a previously unrecognized role of ZBTB7A in negative regulation of melanoma metastasis and have important clinical implications.

Indexed as

Gene Expression ProfilingGene Expression Regulation, NeoplasticAnimalsBinding SitesCD146 AntigenDNA-Binding ProteinsGene DeletionHEK293 CellsHumansLentivirusMelanomaMiceMice, NudeMutationNeoplasm InvasivenessNeoplasm MetastasisCD146 AntigenDNA-Binding ProteinsMCAM protein, humanMcam protein, mouseTranscription FactorsZBTB7A protein, humanZbtb7a protein, mouse

Identifiers

PMID25995384
PMCPMC4543565
OpenAlexW2113846605

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.